Denileukin Diftitox (Intravenous Route)Drug Information provided by: Micromedex
US Brand Names
Denileukin diftitox is used to treat persistent or recurrent cutaneous T-cell lymphoma. This is a rare type of cancer that affects certain white blood cells and causes lesions to develop on the skin.
Denileukin diftitox interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be affected by the medicine, other effects may also occur. Some of these may be serious and must be reported to your doctor. Some effects may occur after treatment with denileukin diftitox.
Denileukin diftitox is to be administered only by or under the supervision of your doctor or other health care professional.